Publication

To patent or not to patent, is that the question?

To patent or not to patent, is that the question?

By | 10 Mar 2016

Should a company file a patent or rely on trade secrets as a form of protection?

Publication

Of mice and patents — Kymab beats Regeneron for insufficiency

Of mice and patents — Kymab beats Regeneron for insufficiency

By | 16 Feb 2016

Key points and lessons from Regeneron Pharmaceuticals Inc. v. Kymab

Publication

Revolutionising genome editing with CRISPR/Cas9: patent battles and human embryos

Revolutionising genome editing with CRISPR/Cas9: patent battles and human embryos

By | 18 Dec 2015

Beatriz San Martin and Hannah Smith Willis write for Cell & Gene Therapy Insights.

Publication

CJEU clarifies application of the Specific Mechanism

CJEU clarifies application of the Specific Mechanism

By | 09 Apr 2015

In 12 February 2015, the Court of Justice of the European Union (CJEU) delivered its decision on the questions referred to it by the Court of Appeal on the interpretation of the Specific Mechanism.

Publication

What is Common General Knowledge?

What is Common General Knowledge?

11 Sep 2014

Teva has successfully revoked a patent owned by AstraZeneca for the treatment of asthma for lack of inventive step.

Publication

Ova but not out: a tale of patents and parthenotes

Ova but not out: a tale of patents and parthenotes

By | 01 Sep 2014

What constitutes a human embryo is important to determine the patentability of certain biotech inventions.

Publication

Safety net for safeners?

Safety net for safeners?

By and | 04 Aug 2014

The CJEU has considered the question of what is meant by 'product' and 'active ingredient' in the Medicinal Product SPC Regulation in a number of cases.

Publication

16th Draft of the Rule of Procedure for the Unified Patent Court (UPC)

16th Draft of the Rule of Procedure for the Unified Patent Court (UPC)

By | 21 Mar 2014

The Preparatory Committee published on its website, the 16th version of the Draft Rules of Procedure of the UPC.

Publication

Sumitomo Chemical reference: When are marketing authorisations valid?

By | 12 Dec 2013

In a recent ruling, the CJEU held that a supplementary protection certificate for a plant protection product cannot be sought on the basis of an emergency marketing authorisation.

Publications RSS